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Objective:We previously reported that more than 60% of synovial mesenchymal stem cells (MSCs) placed
on osteochondral defects adhered to the defect within 10 min and promoted cartilage regeneration. The
efﬁciency of adherence is considered to depend on the interaction between cells and extracellular matrix
(ECM), in which integrins may play some important roles. Divalent cations such as calcium, magnesium,
and manganese may affect functions of integrins, and the integrins may be involved in differentiation of
MSCs. Among divalent cations, magnesium is used in clinical practice as a therapeutic agent and
increases the afﬁnity of integrin to ECM. In this study, we investigated whether magnesium enhanced
adherence and chondrogenesis of synovial MSC through integrins.
Methods: We performed assays for adherence of human synovial MSCs to collagen-coated slides, in vitro
chondrogenesis, ex vivo assays for adherence of human synovial MSCs to osteochondral defect, and
in vivo assays for adherence and cartilage formation of synovial MSCs in a rabbit osteochondral defect
model.
Results: Magnesium increased adhesion of human synovial MSCs to collagen, and this effect was
inhibited by neutralizing antibodies for integrin a3 and b1. Magnesium also promoted synthesis of
cartilage matrix during in vitro chondrogenesis of synovial MSCs, which was diminished by neutralizing
antibodies for integrin b1 but not for integrin a3. Ex vivo analyses demonstrated that magnesium
enhanced adherence of human synovial MSCs to osteochondral defects. In vivo studies in rabbits showed
that magnesium promoted adherence at 1 day and cartilage formation of synovial MSCs at 2 weeks.
Conclusion: Magnesium enhanced adherence of synovial MSCs through integrins, which promoted
synthesis of cartilage matrix at an early phase.
 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Mesenchymal stem cells (MSCs) are useful cell sources for
regenerative medicine1e3. Synovium is a practical MSC source for
cartilage regeneration because of its superior proliferation potential
with autologous human serum and high chondrogenic ability4e10.
Current cell therapy for cartilage regeneration requires invasive
procedures, periosteal coverage, and the use of scaffold11,12. We
recently reported thatmore than60%of synovialMSCs suspended inIchiro Sekiya, Tokyo Medical
artilage Regeneration, 1-5-45
-5803-4020; Fax: 81-3-5803-
maya), muneta.orj@tmd.ac.jp
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s Research Society International. Pphosphate buffered saline (PBS) placed on the osteochondral defect
adhered to the defect in 10 min and promoted cartilage regenera-
tion13. Thismethodmakes it possible to transplant synovialMSCs on
the osteochondral defect arthroscopically; however, any improve-
ment in its efﬁciency for cell adhesion remains in question.
Integrins are a family of cell surface molecules which mediate
adhesive interaction with extracellular matrix (ECM), activate
intracellular pathways, and play important roles in many biological
processes including differentiation14e16. Some functions of integrins
are dependent on interactionwith divalent cations such as calcium,
magnesium, and manganese through a metal ion dependent
adhesion site (MIDAS) andMIDAS-like motives17,18. Among divalent
cations, calcium and magnesium are widely used in clinical prac-
tices as therapeutic agents, and magnesium increases the afﬁnity of
integrins for ligands including ECM in a millimolar concentration19,
while calcium reverses the increased afﬁnity in some cases20.ublished by Elsevier Ltd. All rights reserved.
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suspension might enhance adherence of synovial MSCs to osteo-
chondral defect, increase cartilage matrix synthesis of synovial
MSCs, and ﬁnally accelerate cartilage regeneration. The purpose of
this study was to investigate the effect of magnesium on adherence
and cartilage formation of synovial stem cells through integrins.
The results will clarify some novel functions of integrins and
provide some clues for obtaining better clinical outcome for carti-
lage regeneration with synovial MSCs.
Materials and methods
Isolation and culture of MSCs
The study was approved by an institutional review board, and
informed consents were obtained from all subjects. Human syno-
vium harvested from three donors (27 and 34-year-old males and
a 28-year-old female) during arthroscopic surgery was digested
with 3 mg/ml Collagenase D (Roche Diagnostics, Mannheim,
Germany) for 3 h. The nucleated cells were cultured at a clonal
density in 150 cm2 culture dishes (Nalge Nunc International,
Rochester, NY) in 20 ml a-minimum essential medium (MEM)
(Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (FBS)
(Invitrogen) for 14 days, then replated at 50 cells/cm2, cultured for
14 days, and cryopreserved. The frozen cells were slowly thawed,
plated, and incubated for 4 days. The cells were replated at 50 cells/
cm2 again and cultured for 14 days for analyses.
Skeletally mature Japanese white rabbits weighing 3.0 kg on
average were used. Animal care was in accordance with our insti-
tutional guidelines. Synovium harvested from the right knees
under anesthesia was digested in a 3 mg/ml collagenase type V
(Sigma Aldrich, St. Louis, MO) solution for 3 h. After ﬁltering, the
nucleated cells were cultured at 3106 cells/cm2 for 7 days,
replated at 50 cells/cm2, and cultured for 14 days for analyses.
Cell differentiation
One hundred human synovial MSCs were plated in 60-cm2
dishes and cultured for 2 weeks. For adipogenesis, the mediumwas
changed to adipogenic medium. The cells were cultured for an
additional 3 weeks and stained with Oil red O solution. For osteo-
genesis, the mediumwas changed to osteogenic medium. The cells
were cultured for an additional 4 weeks and stained with alizarin
red solution4,8. For in vitro chondrogenic differentiation, 300,000
human synovial MSCs were pelleted and cultured for 7 and 21 days
in chondrogenic medium containing 500 ng/ml bone morphoge-
netic protein (BMP)-7, (Stryker Biotech, Boston, MA), 10 ng/ml
transforming growth factor (TGF)b3 (R&D Systems, Minneapolis,
MN), and 100 nM dexamethasone (SigmaeAldrich). The concen-
tration of magnesium was adjusted by adding MgCl2. For analyses
of involvement of integrins, the cells were pre-incubated with or
without 20 mg/ml neutralizing antibodies for integrin b1 (P5D2,
R&D Systems) or a3 (P1B5, Santa Cruz Biotechnology, Santa Cruz,
CA) for 1 h, then the cells were pelleted and cultured in chondro-
genic medium containing 0.8 or 5 mM magnesium for 21 days. No
antibodies were re-added during the culture.
Surface epitopes
One hundred thousand synovial MSCs suspended in 200 ml PBS
containing 20 mg/ml of antibody were incubated for 20 min at 4C
and subsequently incubated with R-phycoerythrin-coupled anti
mouse IgG (AbD Serotech, Oxford, UK) for 20 min. Antibodies used
in neutralizing against integrin b1 (P5D2, R&D Systems), a3 (P1B5,
Santa Cruz Biotechnology), a4 (HP2/1, AbD Serotech), a5 (JBC5, AbDSerotech) and isotype control (R&D Systems) were used to detect
epitopes. FITC conjugated antibody for the integrin a2 (AK7, AbD
Serotech), CD44 and CD106 (eBioscience, SanDiego, CA); CD105 and
CD166 (Ancell corporation, Bayport, MN), CD45, CD34, CD90 and
isotype control (Becton Dickinson, Franklin Lakes, NJ) were used. In
double-staining for integrin a2 and a3, phycoerythrin (PE)-conju-
gated antibody for integrin a3 (BioLegend, San Diego, CA) was used.
In vitro cell adhesion assay
Onehundred thousandhuman synovialMSCs suspended in 10 ml
PBS with 0, 0.1, 1, 5, and 10 mM magnesium were placed on 8-well
culture slides with or without type I collagen coating (Becton-
Dickinson) for 10 min. After washing slides with PBS, the number of
cells in 4 high power ﬁelds (HPFs) was counted, and the mean was
determined. For neutralizing against adhesionmolecules, cells were
pre-incubated in PBS 20 mg/ml antibody for integrin b1 (P5D2, R&D
Systems), vascular adhesion molecule 1 (VCAM-1; BBIG-V1, R&D
Systems), activated leukocyte-cell adhesion molecule (ALCAM;
105901, R&D Systems), integrin a2 (P1E6, Abcam, Cambridge, UK),
a3 (P1B5, Santa Cruz Biotechnology), a4 (HP2/1, AbD Serotech), a5
(JBC5, AbD Serotech) and isotype control (R&D Systems) for 1 h.
Immunocytochemical analysis
Ten thousand human synovial MSCs adhering to collagen-coat
slides under 10 mM magnesium were ﬁxed with 99.5% acetone for
15 min. The slides were stained with the integrin a2 (P1E6, Abcam)
or a3 (P1B5, Santa Cruz Biotechnology) (1:1000) for 1 h. After
washing, the slides were stained with goat anti-mouse IgG labeled
with Alexa ﬂuor 488 (Invitrogen) for 1 h. The nuclei were stained
with Hoechst 33342 (Invitrogen). The number of integrin-positive
cells and nuclei was counted using 3 HPFs.
Assay for sulfated glycosaminoglycan (sGAG) content of pellets
After 21 days of culture, pellets were digested for 24 h at 60C in
papain buffer (200 mg/ml papain (SigmaeAldrich) and dissolved in
50 mM phosphate buffer containing 1 M NaCl, 5 mM cysteineeHCl
and 1 mM EDTA). The GAG concentration of supernatant was
determined by the Blyscan-assay (Biocolor Ltd, Newtonabbay,
Ireland) according to manufacturer’s instructions.
Real-time polymerase chain reaction (PCR) analysis
Total RNA was extracted from the pellets cultured for 3 weeks
using QIAzol (Qiagen, Hiden, Germany) and the RNeasy micro kit
(Qiagen). cDNA was synthesized with oligo-dT primer from total
RNA using the Transcriptor High Fidelity cDNA Synthesis kit (Roche
Diagnostics) according to the manufacturer’s protocol. Reverse
transcription (RT) was performed by 30 min incubation at 55C,
followed by 5 min incubation at 85C. Real-time PCR was per-
formed in a LightCycler 480 instrument (Roche Diagnostics) using
FastStart TaqMan Probe Master and TaqMan probes for COL2A1
(#75) and b-Actin (#64) (Roche Diagnostics). After an initial
denaturation step (95C for 10 min), ampliﬁcation was performed
for 40 cycles (95C for 15 s, 60C for 60 s).
DNA content of pellets
UndifferentiatedMSCs and pellets at 21 days were digestedwith
3 mg/ml collagenase, and DNA was prepared with a QIAamp DNA
mini kit (Qiagen). The DNA content was calculated from the
absorbance at 260 nm.
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Human osteochondral fragments at the lateral femoral condyle
were harvested during total knee arthroplasty, and osteochondral
defects at 2.5 mm in diameter were created. Then the defects were
ﬁlled with 1.5105 synovial MSCs labeled with DiI (Molecular
Probes, Eugene, OR) in 8 ml PBS with 0, 1, and 10 mM magnesium.
After 10 min, the fragments were turned over for 10 min. The DiI-
positive cells in the dish were counted after trypsinization, and
the number of the cells attached to the defects was calculated. The
ﬂuorescence images of the entire defect were photographed. The
total ﬂuorescence intensity of the remaining cells in the defect was
determined by measuring the brightness in the defect using Image
J software (National Institutes of Health, Bethesda, MD).
In vivo analyses for adherence and cartilage formation
Knees of rabbits were approached medially under anesthesia.
Osteochondral defects (5 5 mm, 1.5 mm deep) were created in
the trochlear groove. To transplant cells, the defect was ﬁlled with
synovial MSCs suspension, and the knees were held stationary for
10 min with the defect facing upward. For adhesion analyses at 1
day, 2106 allogenic DiI-labeled cells at passage 1 suspended in
30 ml PBS with 5 mMmagnesium or in PBS in the contralateral knee
were used. Total ﬂuorescence intensity over the defect was evalu-
ated by measuring the brightness of the entire defect using Image
J software. The ratio of the ﬂuorescence positive area over the
defect was evaluated by measuring the square measure of the
entire defect and the ﬂuorescence positive area at 1 day. For anal-
yses of cartilage regeneration at 14 and 28 days, 5106 autologous
synovial MSCs at passage 0, suspended in PBS with or without
5 mM magnesium were transplanted in the left knee 7 days after
harvest of synovium from the right knee.
Histological analyses
The specimens were ﬁxed with 4% paraformaldehyde solution,
decalciﬁed, and embedded in parafﬁn. Sections were stained with
safranin-o/fast green. Image J was used for measurement of defects
and safranin-o positive areas. Sections without staining were used
for ﬂuorescence.
For immunohistochemistry, sectionswere treatedwith 0.4 mg/ml
proteinase K (DAKO, Carpinteria, CA) in TriseHCl and normal horse
serum after deparafﬁnization. Primary antibodies for type II collagen
(Daiichi Fine Chemical, Toyama, Japan) and a secondary antibody
of biotinylated horse anti-mouse IgG (Vector Laboratories, Burlin-
game, CA) were employed. Immunostaining was detected
with VECTASTAIN ABC reagent (Vector Laboratories) followed by
3,30-diaminobenzidine staining.
Transmission electron microscopy
Cartilage pellets and regenerated cartilage were ﬁxed with 2.5%
glutaraldehyde and post-ﬁxed with 1% OsO4. After dehydration,
they were embedded in Epon 812. Ultrathin (90 nm) sections were
collected on copper grids, double-stained with uranyl acetate and
lead citrate, and then examined by transmission electron micros-
copy (H-7100, Hitachi, Hitachinaka, Japan)18.
Immunoelectron microscopy
After ﬁxation in 4% paraformaldehyde and 0.1% glutaraldehyde,
pellets were immersed in 2.3 M sucrose for 24 h and frozen in
liquid nitrogen. The frozen sections mounted on silane-coated glass
were placed on droplets of 1% BSA on a Paraﬁlm sheet andsubsequently transferred to droplets of mouse antibody against
collagen type I, type II (diluted to 1:20, Fuji Yakuhin, Japan) and
chondroitin sulfate-proteoglycans (diluted to 1:50, Seikagaku
Kogyo, Japan) for 48 h. They were then incubated with goat anti-
mouse IgGþ IgM conjugated with 10e15 nmF gold colloidal
particles (diluted to 1:50 with 1% BSA in 0.1 M PBS, British Bio Cell
International, UK) for 24 h. The sections were ﬁxed in 2.5% glutar-
aldehyde, post-ﬁxed in a 1% OsO4 solution, and dehydrated in
a graded series of ethanol. Then they were embedded in Epon 812,
stained with uranyl acetate, and examined by TEM21.
Statistical analyses
ManneWhitney U tests were used. A value of P< 0.05 was
considered signiﬁcant.
Results
Magnesium increases adhesion of human synovial MSCs through
integrin a3 and b1
Human synovial cells had a colony forming ability and multi-
differentiation potentials [Fig. 1(A)]. Flow cytometric analyses
demonstrated that human synovial cells expressed CD44, 90, 105,
166 highly, and CD34, 45, 106 at a low level [Fig. 1(B)]. These
ﬁndings demonstrated that human synovial cells had characteris-
tics similar to those of MSCs.
Magnesium increased the number of synovial MSCs attached to
collagen-coated slides dose-dependently [Fig. 1(C)]. Time lapse
analysis showed that 5 mM magnesium caused thinning of cell
shape and spread the cells on collagen-coated slides within 5 min,
while the cell was still thick and round even after 25 min without
magnesium or collagen-coating [Fig. 1(D)]. Human MSCs also
expressed integrin a5, b1 highly, integrin a2, a3 modestly, and
integrin a4 at a low level [Fig. 1(B)]. The effect of magnesium on
attachment of synovial MSCs was diminished by the neutralizing
antibodies for integrin a3 and b1 [Fig. 1(E)]. Some studies have
reported that a2 integrin was a collagen receptor14,15, therefore, we
attemptedmore detailed examinations of antibodies for integrin a2
and a3. Double staining ﬂow cytometric assay showed that the
double positive rate was only 17% [Fig. 1(F)]. Immunocytochemical
analysis showed that the a2 positive cell rate was 38%, and the a3
positive cell ratewas 73% among cells adhering to the collagen slide
in the presence of 10 mM magnesium [Fig. 1(G)].
Magnesium enhances chondrogenesis of human synovial MSCs
In pellet culture for in vitro chondrogenesis, the weight of the
pellets at 7 days was affected by magnesium concentration, and
5 mM magnesium had the greatest effect [Fig. 2(A)]. The weight of
the pellets cultured in 5 mM magnesium for 21 days was also
heavier than those cultured in 0.8 mM magnesium in three other
donors [Fig. 2(B left)]. Pellets cultured in 5 mM magnesium
produced more sGAG than pellets cultured in 0.8 mM magnesium
[Fig. 2(B, right)].
Pretreatment with neutralizing antibody for integrin b1 resulted
in a decrease of pellet weight, sGAG content and safranin-o staining
in pellets cultured in 5 mMmagnesium at 21 days [Fig. 2(C)]. Pellets
cultured in 5 mM magnesium showed higher COL2A1 expression
than pellets cultured in 0.8 mM magnesium [Fig. 2(D)]. The DNA
content of pellets greatly decreased in 3 weeks, and no signiﬁcant
difference was observed between pellets cultured in 0.8 and 5 mM
magnesium [Fig. 2(E)].
Transmission electron microscopy revealed polygonal cells
with short processes, containing well-developed rough
Fig. 1. Properties of human synovial MSCs and magnesium effects on adherence. (A) Macroscopic images of adipogenic and osteogenic differentiation of colony forming cells.
(B) Surface epitopes. (C) Microscopic images and quantiﬁcation of adherent cells on collagen-coated slides at indicated concentrations of magnesium. Values are means with 95%
conﬁdence interval (CI) (n¼ 3). (D) Time-lapse analyses of cell morphology during their adhesion on collagen coated slides with or without magnesium. (E) Microscopic images and
quantiﬁcation of adherent cells pretreated with neutralizing antibodies. Values are means with 95% CI (n¼ 3). (F) Two-dimensional plotting for integrin a2 and a3 (red), and for the
isotype controls (blue). (G) Immunocytochemical analysis for integrin a2 and a3 of adhering cells on collagen-coated slides in the presence of 10 mM magnesium. The number of
positive cells (green) and nuclei (blue) was counted using 3 HPFs, and the integrin positive ratio was calculated. Values are means with 95% CI (n¼ 3).
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striated collagen ﬁbrils in pellets cultured for 21 days even in
0.8 mM magnesium. Thick collagen bundles consisting of a large
number of parallel collagen ﬁbers characteristic for ﬁbro-
cartilage22,23 could not be seen [Fig. 2(F, upper panels)].Immunoelectron microscopic analysis demonstrated expres-
sions of type II collagen, chondroitin sulfate, and the absence of
type I collagen in ECM [Fig. 2(F, lower panels)]. These results
indicate that pellets of synovial MSCs differentiated into hyaline
cartilage.
Fig. 2. Magnesium effects on in vitro chondrogenesis of human synovial MSCs. (A) Pellet cultured in chondrogenic medium at indicated concentration of magnesium. Macroscopic
images at 1 week (upper, scale¼ 1 mm) and quantiﬁcation of wet weight of pellets at 1 week (lower). Values are means with 95% CI for three pellets from one donor. (B) Wet weight
(left) and sGAG content (right) of pellets cultured for 21 days in 0.8 and 5 mM magnesium. Values are means with 95% CI for three pellets from each donor. (C) Pellets of MSCs
pretreated with antibodies. Pretreated pellets were cultured in chondrogenic medium at 0.8 and 5 mM magnesium for 21 days. Macroscopic images with 1 mm scale (left),
histologies stained with safranin-o (middle), and relative weight and sGAG content of pellets cultured in 5 mM magnesium to those cultured in 0.8 mM magnesium (right). Values
are means with 95% CI (n¼ 3). (D) Real time PCR analysis for gene expression of Col2A1 in pellets cultured for 21 days in 0.8 or 5 mM magnesium. b-Actin was used as an internal
control. Values are means with 95% CI (n¼ 3). (E) DNA content of pellets at day 0 and day 21. Values are means with 95% CI (n¼ 3). (F) Transmission electron microscopic image
(upper left), the magniﬁed image (upper right) and immunoelectron microscopic images (lower) of pellets cultured for 21 days in chondrogenic medium containing 0.8 mM
magnesium. The arrows indicate collagen ﬁbrils (upper right).
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osteochondral defects in vitro
Macroscopic and ﬂuorescence observations indicated that DiI
labeled MSCs in the defect increased along with magnesium
concentration. The intensity of DiI ﬂuorescence of MSCs sus-
pended in 10 mM magnesiumwas signiﬁcantly higher than that inPBS without magnesium [Fig. 3(A)]. Histological analyses also
indicated an increase of DiI-labeled cells in the defect along with
magnesium concentration, and that the number of adherent MSCs
in 10 mM magnesium was signiﬁcantly higher than that in PBS
without magnesium [Fig. 3(B)]. The ﬂuorescence intensity of the
defects signiﬁcantly decreased with antibodies for integrin a3 or
b1 [Fig. 3(C)].
Fig. 3. Ex vivo studies for magnesium effects on adherence of human synovial MSCs on
osteochondral defects. (A) Top side view of the osteochondral defects without ﬂuo-
rescence (left upper), with ﬂuorescence (left lower), and quantiﬁcation of the relative
ﬂuorescence intensity of DiI labeled MSCs in the defects (right). Values are means with
95% CI. Four pieces of osteochondral fragments were used for each group. (B) Histo-
logical analyses and quantiﬁcation of attached cell number. Toluidine blue staining (left
upper), the ﬂuorescence image for DiI (left lower), and quantiﬁcation of adherent cell
number (right). Values are means with 95% CI. Four pieces of osteochondral fragments
were used for each group. (C) Effects of the neutralizing antibodies. Top side view of
the defects without ﬂuorescence (upper) and with ﬂuorescence (middle). The relative
ﬂuorescence intensities of cells in the defects were quantiﬁed (lower). Values are
means with 95% CI. Three pieces of osteochondral fragments were used for each group.
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osteochondral defects in vivo
Osteochondral defects in the rabbit knee joint were ﬁlled with
DiI-labeled MSCs suspended in PBS with or without 5 mMmagnesium, held stationary for 10 min [Fig. 4(A)], and then the
joint capsule was closed. Under ﬂuorescence at day 1, the DiI
positive area was more distinct [Fig. 4(B, upper panels)], and the
ﬂuorescence intensity of defects [Fig. 4(B, lower left)] and the ratio
of ﬂuorescence positive area over the defect [Fig 4(B, lower right)]
were signiﬁcantly greater in the defect treated with magnesium.
Histologically, a greater number of DiI-positive cells adhered to the
defect treated with magnesium. Furthermore, a greater number of
cells accumulated on the layer of cells which are attached to the
basement of defects in the presence of magnesium [Fig. 4(C)].
Addition of magnesium results in a greater amount of cartilage
matrix by MSCs in vivo
At 2 weeks, cartilage matrix stained with safranin-o appeared
more distinct in the osteochondral defect treated with synovial
MSCs suspended with magnesium than in the defect treated with
synovial MSCs suspended without magnesium [Fig. 5(A)]. The
safranin-o positive area ratio was signiﬁcantly higher in the defect
treated with magnesium [Fig. 5(B)]. At 4 weeks, the amount of
cartilage matrix increased, and the difference of the ratio of the
safranin-o positive area to the defect area lessened in both groups.
The matrix of regenerated cartilage was positive for type II collagen
in both groups [Fig. 5(C)]. Regenerated cartilage consisted of
polygonal cells containing well-developed rER, with short
processes, and surroundedwith thin, faintly striated collagen ﬁbrils
[Fig. 5(D)]. These results indicate that the osteochondral defect was
regenerated with hyaline cartilage.
Discussion
MSCs are deﬁned as having been derived from mesenchymal
tissue and by their functional capacity to self-renew and to
generate a number of differentiated progeny1,10. Since the earliest
studies by Friedenstein et al., the standard assay used to identify the
self-renewal ability of MSCs is the colony forming unit ﬁbroblast
assay24. Although clonal colonies of MSCs are readily prepared, they
rapidly become heterogeneous as they expand9,25,26. We collected
bulk colony-forming cells, and the cells used in the present study
showed both colony-forming ability and multipotentiality. Surface
markers were also identical to those of MSCs published else-
where1,4,7e10. Therefore, the synovial cells we used were deﬁned as
MSCs, though the cells were not clonal. This point should be
considered when our study is discussed in the ﬁeld of “stem cells”.
It was reported that magnesium enhanced adhesion of some
tumor cells or lineage cell lines to collagen and ﬁbronectin coated
slides. Grzesiak et al. demonstrated that human ﬁbroblast WI38
bound to type I collagen under regulation by shift in the concen-
trations of extracellular divalent cations. In their report, cells
adhered to collagen more effectively along with the concentration
of magnesium through integrins20. However, there have been no
reports demonstrating that magnesium enhanced adhesion of
MSCs to collagen coated slides or osteochondral defects. Further-
more, improvement of the efﬁciency of attachment of stem cells is
currently one of the topics for stem cell biology and regenerative
medicine. An increase in adherence of cells leads to the improve-
ment of “efﬁciency of transplantation,” a factor of increasing
interest in cell based regenerative medicine27. We believe that this
paper contributes greatly to the ﬁeld of cell therapy for regenerative
medicine.
Although Pittenger et al. reported that bone marrow MSCs
expressed integrins a1, a2, a3, and b1, integrins expressed in
human synovial MSCs have not been reported1. In this study,
surface epitope analyses revealed that synovial MSCs expressed
integrin a5 and b1 highly, and a2 and a3 moderately.
Fig. 4. In vivo analyses for magnesium effects on adherence of rabbit synovial MSCs on osteochondral defects. (A) Procedure for cell transplantation. Osteochondral defect was
created, and needle was prepared over the defect (left). Cell suspension was dripped onto the defect, and this position was kept for 10 min (right). (B) Macroscopic and macroscopic
ﬂuorescence images of the defect for DiI labeled MSCs (upper six panels), quantiﬁcation of relative ﬂuorescence intensity over the defect at 1 day (lower left) and the ratio of
ﬂuorescence positive area over the defect at 1 day (lower right). The ratio was evaluated by measuring the square measure of the entire defect and the ﬂuorescence positive area
within the defect. Values are means with 95% CI (n¼ 3). (C) Sagittal sections of histologies stained with toluidine blue (upper), for DiI (middle) and the magniﬁed image (lower).
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cuous cell adherent receptor. Wayner et al. ﬁrst identiﬁed Integrin
a3b1 as a receptor for type I, and IV collagen, laminin, and ﬁbro-
nectin28. Berdichevsky et al. reported that antibody for integrin a3
inhibited adhesion to polymerized collagen in mammary epithelial
cells29. Carter et al. reported that human keratinocytes cultured on
ﬁbronectin, collagen, or laminin were detached from cover slips in
the presence of anti integrin a3 antibody30. Though integrin a2b1 is
also considered as one of the collagen receptors14,15, our results
demonstrated that neutralizing antibodies for a3 and b1 inhibited
adhesion of synovial MSCs on collagen-coated slides. This indicates
that integrin a3b1 functions as an adherence factor of synovial
MSCs to type I collagen-coated slides under a higher concentration
of magnesium.
In this study, we evaluated in vitro chondrogenesis potential as
pellet weight. We intensively investigated pellet culture of MSCs.
During in vitro chondrogenesis of MSCs, the pellets increased in size
and weight. Conversely, the DNA yield per pellet decreased. The
radioactivity per DNA in the cells, assessed by prelabeling with
3H-thymidine, was stable during in vitro chondrogenesis of MSCs.
The increase in pellet size can be attributed to production of ECM
and not to the proliferation of the cells5,31. Pellet weight is always
correlated with expressions of cartilage related mRNAs such as
COL2A1, aggrecan, link protein, SOX5, SOX6, and SOX9. Pellet
weight is also correlated with proteoglycan staining by safranin-o,type II collagen by immunostaining, protein expressions of chon-
droitin 4-sulfate, chondrotitin 6-sulfate, and hyaluronan by ELISA
as we previously reported4e9,25,32. All the results demonstrate that
the weights of the pellets are quantitative indicators for chondro-
genesis of MSCs.
While magnesium did not affect the DNA content of pellets,
magnesium increased the wet weight, sGAG content, and gene
expression for type II collagen of pellets. The effect was signiﬁcantly
diminished after pretreatment with neutralizing antibody for
integrin b1 without re-adding antibodies. We investigated
sequential gene expression proﬁles of MSCs during in vitro chon-
drogenesis within 24 h, and a large number of gene expressions
were dramatically altered within a few hours (data not shown).
Also, our morphological analysis demonstrated that the ultra-
structure was altered most dramatically within 1 day21. We spec-
ulated the effect of neutralizing antibody for integrin b1 as follows:
The neutralizing antibody for b1 integrin affected in vitro chon-
drogenesis at an early period, and this inﬂuence remained at a later
stage, resulting in a difference of synthesis of cartilage matrix. We
examined the magnesium effect on adherence of rabbit synovial
MSCs on osteochondral defects in vivo. DiI-labeledMSCs suspended
in PBS with or without 5 mM magnesium were placed on the
defects for 10 min, and then the rabbit was allowed to move freely
after operation. The distributions of DiI positive MSCs in the defects
at 1 daywere less homogenous compared with the results of ex vivo
Fig. 5. In vivo analyses for magnesium effects on cartilage regeneration with rabbit synovial MSCs. (A) Sagittal section of defects stained with safranin-o at 2 and 4 weeks. (B) Ratio
of safranin-o positive area to the total defect area at 2 and 4 weeks. Values are means with 95% CI (n¼ 3). (C) Immunohistochemistry for type II collagen at 4 weeks. (D) Trans-
mission electron microscopic image of cell in regenerated cartilage of rabbit treated with synovial MSCs suspended in PBS at 4 weeks (left) and the magniﬁed image (right). The
arrows indicate collagen ﬁbrils.
M. Shimaya et al. / Osteoarthritis and Cartilage 18 (2010) 1300e1309 1307analysis. Intra-articular circumstance caused a discomfort condi-
tion for MSCs to continue in their attachment to osteochondral
defects due to gravity force, bleeding, inﬂammatory reactions, and
mechanical stresses accompanied with joint motions.
During in vivo situation, magnesium increased adherence of
MSCs to the basement of the defect. Histologically, a greater
number of cells accumulated on the layer of cells which were
attached to the basement of the defects in the presence of
magnesium. There are two possibilities to account for the result.Fig. 6. Scheme of MSC based cartilage regeneration with magnesium. Magnesium increas
without toxicity.Magnesium alsomay enhance accumulation of MSCs on the layer of
the cells. Otherwise, a greater number of single-layered cells on the
basement of defect may enhance accumulation of MSCs dependent
on or independent of magnesium.
In vivo studies showed that cartilage matrix was regenerated
earlier in the defects treated in the presence of 5 mMmagnesium at
2 weeks. The number of cells involved in regeneration of cartilage is
an important factor33. The difference of initial cell number attached
to the defect or initial magnesium concentration may have been anes MSC attachment and cartilage matrix formation through integrins at initial stage
M. Shimaya et al. / Osteoarthritis and Cartilage 18 (2010) 1300e13091308inﬂuencing factor even after 2 weeks. As a whole, the presence of
magnesium in cell suspension promoted cell adhesion to osteo-
chondral defects and exerted no toxic effect on in vivo cartilage
formation.
Standard media for cell culture, which also promote cell
attachment, are not usually approved for clinical use. The most
popular standard solution for clinical use is a lactate Ringer’s
solution, which does not contain magnesium. To demonstrate the
effect of magnesium experimentally, we selected PBS (), which is
a more simpliﬁed standard solution close to a lactate Ringer’s
solution. PBS (þ) contains 0.8 mMmagnesium, andwe showed that
5 mMmagnesium had stronger effects for attachment and cartilage
formation of synovial MSCs than PBS (þ) containing 0.8 mM
magnesium. Even if we had used PBS (þ) as a control, the results
would not have been signiﬁcantly affected.
In summary, magnesium enhanced attachment of synovial
MSCs to osteochondral defect through integrin a3b1. A greater
number of MSCs were attached to the defect and promoted
synthesis of cartilage matrix at an early phase. Furthermore,
magnesium increased cartilage matrix synthesis through integrin
b1 during in vitro chondrogenesis of synovial MSCs (Fig. 6).
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